Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Milky Way Biotech ApS
APS
Bankrupt
CVR 44005255
Centrifugevej 374
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2023
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -4K
EBITDA margin
100.0%
Equity ratio
23.7%
Financial strength
Net profit 2024
DKK -8K
2 employees
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2024
Key figures
Annual report 2024
Revenue
DKK -4K
—
EBITDA
DKK -4K
—
Net profit
DKK -8K
—
Total assets
DKK 137K
—
Equity
DKK 32K
—
Employees
2
—
Company information
Legal name
Milky Way Biotech ApS
CVR number
44005255
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. april 2023
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-04-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Centrifugevej 374
Phone
+4550285875
Email
szoboszlai.c.patrik@gmail.com
Recent events
1 entries
Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Lyngby-Taarbæk
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
DKK thousands
Item
2024
Revenue
-4
Staff expenses
-0
EBITDA
-4
Depreciation & amort.
-0
EBIT
-4
Net financials
-4
Profit before tax
-8
Tax
-0
Net profit
-8
Balance sheet
DKK thousands
Item
2024
Total assets
137
Equity
32
Long-term debt
0
Short-term debt
104
Total debt
104
Financial ratios
5-year trend
EBITDA margin
-397900.0%
This company
15.8%
Market median
-2518454% vs market
2024
2024
Equity ratio
23.7%
This company
38.2%
Market median
-38% vs market
2024
2024
Return on equity
-23.1%
This company
18.4%
Market median
-226% vs market
2024
2024
Net profit margin
-750700.0%
This company
8.1%
Market median
-9268001% vs market
2024
2024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
2024
2024
Debt / equity
3.21×
This company
0.62×
Market median
-418% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-04-17 – 2024-04-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MD
Mario Diego Alzamora Fernandez
Management
Management
2023
—
—
TG
Teis Gullitz-Wormslev
Unofficial title
Unofficial title
2025
—
—
PK
Patrik Károly Szoboszlai
Management
Management
2023
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Alzamora Holding ApS
Company
50.0%
50.0%
2023
Szoboszlai Holding ApS
Company
50.0%
50.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Szoboszlai Holding ApS
Milky Way Biotech ApS
(this company)
Board network connections
Board members of Milky Way Biotech ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Mario Diego Alzamora Fernandez
Management
0 companies
Teis Gullitz-Wormslev
Unofficial title
0 companies
Patrik Károly Szoboszlai
Management
0 companies